Top compounds associated with response to C2orf50


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA MS-275 GDSC1000 pan-cancer AAC 0.11 0.02
mRNA EX-527 CTRPv2 pan-cancer AAC 0.083 0.03
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.03
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.082 0.03
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.074 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA Z-LLNle-CHO GDSC1000 pan-cancer AAC 0.098 0.03
mRNA Erlotinib CCLE pan-cancer AAC -0.094 0.04
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.04
Download CSV